Surgical considerations for neuroblastoma-associated opsoclonus–myoclonus–ataxia syndrome: a series of 14 patients from a single institution

Single-institution review of 14 neuroblastoma patients with opsoclonus-myoclonus-ataxia syndrome demonstrates correlation between tumor burden and paraneoplastic symptoms, with OMAS developing after partial resection and recurring with tumor recurrence. Findings support aggressive surgical resection even for low-risk tumors and consideration of neoadjuvant therapy for cases with image defined risk factors.